show episodes
 
Artwork

1
The Top Line

Fierce Life Sciences

icon
Unsubscribe
icon
icon
Unsubscribe
icon
Weekly
 
Biopharma and medtech explained. Every week, journalists from Fierce Biotech, Fierce Medtech, and Fierce Pharma recount the latest industry trends and why they matter. We'll analyze the week's biggest business news, from mergers and marketing to drug R&D and device development. Available every Friday morning.
  continue reading
 
The Pharma Letter Podcast provides in-depth discussion and analysis focused on key trends, companies and events in the pharmaceutical and biotech industries. Our guests come from a broad array of sectors and business functions, from early stage research in biopharmaceuticals, to patient engagement and marketing, supply chain management and life sciences investing. Podcasts are typically 20-30 minutes in length and are released approximately once every two weeks.
  continue reading
 
Welcome to Biotech Bulls & Breakthroughs! This brand new podcast from BioPharmCatalyst explores the dynamic world of biotech investing alongside long-time biotech trader Sheff from Sheff Station. Each month, we will be discussing current events in the biotech industry and how these events impact investors, as well as a discussion of upcoming catalysts in the biotech space.
  continue reading
 
The Off Script podcast offers in-depth interviews and discussions with industry experts about hot-button topics in pharma, and goes behind the scenes of Pharma Manufacturing’s print and online coverage, which follows the industry’s biggest issues surrounding scale-up, technology innovations, regulations and more!
  continue reading
 
Artwork

1
BioBiz Buzz

https://biobizbuzz.com/

icon
Unsubscribe
icon
icon
Unsubscribe
icon
Monthly+
 
BioBiz Buzz offers exclusive insights into the biotech, pharma, and medtech industries through interviews with top executives and visionaries. Providing thought-provoking podcasts covering topics such as scientific advancements, emerging technologies, and market trends, to keep listeners informed about the latest developments in life sciences. Disclaimer https://biobizbuzz.com/disclaimer/
  continue reading
 
Citeline places biopharma and medical device professionals, and those who focus on these industries, at the forefront of knowledge and insight, by providing the perfect combination of news and information together with penetrating insight and analysis. Citeline is a leader in the field of healthcare industry information.
  continue reading
 
This Life Science focused podcast brings together Xtalks editorial staff to share insights into the latest B2B industry news. Xtalks connects professionals in the life science, medical device, and food industries with useful content like webinars, job opening, articles and virtual meetings.
  continue reading
 
Hosted by Melissa Lee and a roundtable of top traders, “Fast Money” breaks through the noise of the day, to deliver the actionable news that matters most to investors. Fast Money airs weeknights at 5p ET on CNBC. Visit http://fastmoney.cnbc.com for additional information.
  continue reading
 
Artwork

1
Life Science Today

Noah Goodson, PhD

icon
Unsubscribe
icon
icon
Unsubscribe
icon
Monthly
 
Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of pe ...
  continue reading
 
Artwork
 
The impact of modern medicine on the human condition can’t be underestimated. From antibiotics to vaccines, medicine has changed the way our bodies work, answered deadly questions, and promised faster cures. But it’s not simple. Drug development is rife with tension. It costs a lot of money, and takes a long time. Most things fail. But when they succeed, they can make a tremendous difference in people’s lives. Where will the next breakthroughs come from? How will we pay for them? Who decides ...
  continue reading
 
Artwork
 
The Prospect Group is a leading global firm specializing in media, research, and consulting. We meet, and discuss the most relevant economic issues with, hundreds of the world’s leading business executives, political elites, and other influential personalities from a cross-section of industries and countries. Watch video interviews from and/or about Malaysia.
  continue reading
 
This is Politics & Life Sciences (PLS) Radio which is an interplay of Life Sciences and Politics. I am your host Dean L. Fanelli, Ph.D. I am an Intellectual Property attorney in Washington, DC. My practice focuses on issues attendant to the Life Sciences industry. On PLS, we will explores cutting edge topics involving the Biotech and Pharma ecosystems and looks at political or governmental policy issues affecting the Biotech and Pharma industries. Each week, PLS will have amazing guests incl ...
  continue reading
 
Join Hercules Capital in conversations with today’s top CEOs, CFOs, and investors in venture and private equity-backed companies. Learn about their strategies for financing rapid growth and scaling their businesses, as well as their unique interests and life stories that have shaped their paths to success.
  continue reading
 
Are you working in healthcare market research or competitive intelligence or market intelligence? Do you often face information overload, from the pharma news portals, clinical trial registries, regulatory agencies, financial reports, investor releases, pharma summits, investment news, and financial summits etc.? It is hard to keep a track of all the forces (external and internal) that affects a product’s development and performance in the healthcare/ pharmaceutical market. We at RAS Life Sc ...
  continue reading
 
Mondays: Tom Deep Dives. Tuesday and Wednesdays: In Depth Interviews. Thursdays: The Tom Bilyeu show. Fridays: Tom Bilyeu Live! Uncover the truth behind the headlines and memes in an unbiased pursuit of what’s real. From interviews and reactions to debates on the most important topics of the day, this podcast will challenge everything you know about current events, the economy, culture, and more. Tom Bilyeu’s Impact Theory helps you thrive in our complex world. Hosted by Tom Bilyeu, a promin ...
  continue reading
 
Loading …
show series
 
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.Former FDA official Peter Marks criticized the agency's new risk-based COVID-19 vaccine framework, stating it contradicts the administration's transparency and science standards. The CDC's advisory committee recommended M…
  continue reading
 
Nvidia becomes the first company to cross the $4T market cap, as the chip giant helps fuel the Nasdaq to its own record high. How the semi surge is fueling the broader tech trade, and if the gains can continue. Plus Is it time for an Apple turnover? Why one Wall Street research firm thinks it’s time for Tim Cook to be replaced, and how a new chief …
  continue reading
 
In this episode of the Xtalks Life Science Podcast, host Ayesha Rashid speaks with Edwin Tucker, MD, MBA, Chief Medical Officer (CMO) at Jasper Therapeutics, about innovative approaches to treating chronic mast cell diseases such as asthma, food allergies and IBS. Dr. Tucker has over 30 years of clinical drug development experience, with past roles…
  continue reading
 
Fan Favorite: This episode originally aired on January 11, 2022. Tom Bilyeu gives business advice to Jesse Dow of Grit and Diamonds, a coffee based product that's designed to be great for the skin. Learn more about the product and business here: https://www.gritanddiamonds.com/ StartUp Theory is a series in which founder of Impact Theory and co-fou…
  continue reading
 
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.Medical societies, including the American Academy of Pediatrics, have filed a lawsuit against RFK Jr. over changes to COVID-19 vaccine policies. They argue that his directive to remove COVID-19 from vaccination guidelines…
  continue reading
 
Big banks head lower as investors scoop up beaten down sectors like small caps, healthcare, and airlines. Could the next great rotation in the market be underway? Plus Coreweave shedding some of its gains after the company announced a data deal, and the acquisition is fueling Wall Street pessimism on the name. What one top analyst sees in store for…
  continue reading
 
In the latest episode of the Health Matters podcast, Wendy Lund sits down with Peter Pitts, former FDA associate commissioner and current president of the Center for Medicine in the Public Interest, to discuss the state of regulatory science and communication in health care. Pitts shares a cautiously optimistic outlook for the FDA under Commissione…
  continue reading
 
Tom and co-host Drew dive deep into a jam-packed week of controversy, conspiracy, and current events. They kick things off with the latest whirlwind around the long-awaited Epstein list, exploring why both the FBI and political powers might be protecting it, and what this means for public trust. The conversation expands to America’s fiscal cliff, w…
  continue reading
 
Good morning from Pharma and Biotech Daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.Kalvista has received approval for the first on-demand hereditary angioedema pill after facing challenges with the FDA. Meanwhile, Robert F. Kennedy Jr. has made significant cuts and rehires at the Department of Health an…
  continue reading
 
President Trump announcing 25% tariffs on goods from Japan and South Korea, and a handful of other countries are also in the crosshairs. What it means for markets, as they back off record levels. Plus biotech stocks have been on the upswing since April. Can the trend continue? We talk to one top analyst to find out. Fast Money Disclaimer…
  continue reading
 
AMERICA’S DEFICIT RECKONING: What happens if the U.S. doesn’t rein in the budget deficit? CNBC Senior Finance & Banking Reporter Leslie Picker interviewed a dozen experts, investors and former government officials over the course of five months to explore the consequences of America’s fiscal path – not how to solve it, but what’s at stake if we don…
  continue reading
 
Ying Tam, Chief Scientific Officer at Acuitas Therapeutics, discusses the company's role in delivering the first personalized CRISPR gene editing treatment to an infant with CPS-1, achieving treatment in just six months from diagnosis. Tam shares insights on evolving lipid nanoparticle technology beyond COVID vaccines, including LNPs that allow for…
  continue reading
 
Tom Bilyeu takes us on a deep dive into the cautionary tale of Argentina—a country that once stood shoulder to shoulder with the world’s wealthiest nations, only to crumble under the weight of hyperinflation, runaway debt, and political promises of “free stuff.” Drawing powerful parallels between Argentina’s century-long decline and the current eco…
  continue reading
 
According to a recently published study by Bayer Consumer Health, being poor makes it more likely that you will suffer from self-treatable health conditions. But it also means you will find it harder to take advantage of self-care solutions. In this episode of the Over the Counter podcast, HBW Insight speaks to Bayer Consumer Health’s global medica…
  continue reading
 
Good morning from Pharma and Biotech Daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.## Breakthrough in Cancer TreatmentExciting news in the world of oncology as a new breakthrough in cancer treatment has been announced. Researchers have discovered a novel therapy that targets specific mutations in cancer…
  continue reading
 
Audio roundup of selected biopharma industry content from Scrip over the business week ended July 4, 2025. In this episode: AbbVie’s big autoimmune CAR-T play; In Vivo CAR-T interest grows; China deal perspectives from BIO; global pharma interest in Korea undeterred; and a look at the biggest drug sales disappointments. https://insights.citeline.co…
  continue reading
 
Fan Favorite: This episode originally aired on August 14, 2018. Footballer turned dance star, Will "Willdabeast" Adams took the attention earned on America’s Got Talent and became the entertainment industry’s go-to choreographer. His high-energy dance videos and undeniable work ethic helped create ImmaBEAST, a community dedicated to elevating and u…
  continue reading
 
In today’s jam-packed discussion, Tom and co-host Drew tackle some of the most pressing issues shaping today’s world—from the latest midnight vote in the Senate and its sweeping impact on government spending, taxes, and entitlements, to America’s mounting debt crisis and what fiscal responsibility really looks like going forward. The conversation d…
  continue reading
 
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world. Health Secretary Robert F. Kennedy Jr. endorsed the expanded use of RSV vaccines for people aged 50-59 who are at risk of severe disease, following recommendations from ACIP members he had previously fired. Biogen CEO Ch…
  continue reading
 
As the opioid crisis continues to devastate communities worldwide, millions suffering from chronic and neuropathic pain face a critical dilemma: enduring debilitating pain or risking addiction with traditional opioid medications. In this episode of BioBiz Buzz, host Mike Ward explores one of modern medicine's most pressing challenges with Per von M…
  continue reading
 
Welcome to Impact Theory with Tom Bilyeu, where today’s episode dives headfirst into the hottest political and cultural debates making waves right now. Tom is joined by Co-Host Producer Drew, RFK, and Candace Owens as they dissect everything from the controversial “Big Beautiful Bill” passing through the Senate to Elon Musk’s fiery reaction and pus…
  continue reading
 
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world. A judge has suspended mass layoffs at the Department of Health and Human Services, ruling that the staff cuts are likely unlawful as the agency does not have the authority to make such changes without Congress. In other …
  continue reading
 
世界の製薬ビジネスを伝える「Scrip」と、各国で変化する製薬関連の規制に特化した「Pink Sheet」。普段は英語で発信する2つのオンラインメディアから、今注目の話題を日本語で短くまとめてお届けします。今回取り上げた記事はこちらSnapshot Of India’s Pharma Manufacturing Network Amid ‘Trumponomics’(邦訳:インド、医薬品製造ネットワークの現在地 「トランプ経済政策」の最中で)https://insights.citeline.com/scrip/focus-on-asia/india/snapshot-of-indias-pharma-manufacturing-network-amid-trumponomics-4NDNA…
  continue reading
 
Shares of Microsoft falling, as reports the tech giant is scaling back plans for AI server chips. What it means for the company as the AI revolution continues, and the impact of Microsoft’s biggest round of layoffs since 2023. Plus Intel’s Foundry Changes. What the beaten down chip company is planing for its foundry business, and how the new CEO is…
  continue reading
 
In this episode, Ayesha spoke with Adam Grant, PhD, Principal Scientist at CancerVax, to discuss the company’s Universal Cancer Treatment Platform. The immunotherapy tool uses AI to train the immune system to recognize and eliminate cancer cells by modifying those cells to resemble known pathogens like measles. This innovative approach prompts a st…
  continue reading
 
How is venture philanthropy revolutionizing Alzheimer's drug discovery? We sit down with Karen Harris, CFO at the Alzheimer's Drug Discovery Foundation, to explore their game-changing approach to funding early-stage research.With $370M+ awarded to 765+ programs globally, the ADDF operates like a VC firm—using convertible debt and preferred equity t…
  continue reading
 
This is a Fan Fav episode. Welcome to Impact Theory where I’m going for a deep dive into the art of seduction with best-selling author and expert strategist, Robert Greene. Known for his profound understanding of human nature, Greene shares game-changing insights that are a game-changer in your dating approach and what women will find attractive ab…
  continue reading
 
In the first episode of this new China Biopharma English-language mini podcast, Shanghai-based senior reporter Xu Hu looks at the main directions in which obesity drug developers are moving, Chinese pharma firms’ position in the global race for muscle-preserving weight loss drugs and China's challenge in matching accessible drugs with well-guided w…
  continue reading
 
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world. Beckley's psychedelic nasal spray, BPL-003, has successfully cleared Phase II trials for treatment-resistant depression, showing robust efficacy data. Analysts predict the asset could reach peak market sales of $1 billio…
  continue reading
 
A market rotation is underway, as investors transition from this year’s best performing sectors into some underperformers. The areas seeing some action, and if it will continue through the summer. Plus A technical twofer on Apple, as the Chartmaster Carter Worth and Kaite Stockton of Fairlead Strategies dig into a short-term play on Apple. Fast Mon…
  continue reading
 
While macroeconomic uncertainty weighs on the sector, there are glimmers of hope in some areas of pharmaceutical outsourcing and services.Greg Slabodkin Read by Brittany Duncan Read Article Here: https://www.pharmamanufacturing.com/editors-review/article/55299879/editors-review-is-the-biopharma-industrys-glass-half-empty-or-half-full…
  continue reading
 
What's up, guys? I have a powerhouse episode for you today with Eli Lake—one of the sharpest minds in foreign policy journalism. Eli's a columnist for the Free Press, the host of the Breaking History podcast, and a straight-up expert on everything from intelligence to Middle East geopolitics. If you’ve ever found yourself wondering what's really be…
  continue reading
 
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world.AbbVie's acquisition of Capstan Therapeutics for $2.1 billion highlights the increasing trend of mergers and acquisitions in the biopharmaceutical industry. This move gives AbbVie access to Capstan's novel in vivo CAR T the…
  continue reading
 
The first half of the year is in the books, and stocks closed it out touching fresh record highs. But can the climb continue in the back half? Where RBC’s Lori Calvasina sees the market heading next. Plus Oracle’s next move after the company announces some cloud deals, and a check on the China trade after the country’s manufacturing data shrinks fo…
  continue reading
 
With growing FDA bottlenecks and regulatory changes, this episode explores how biotechs are looking beyond borders by rethinking trials, embracing real-world data, and finding new global pathways to bring therapies to life.Small Biotechs, Big Decisions is a limited podcast series exploring the challenges and opportunities facing emerging biotech co…
  continue reading
 
In today’s episode, Tom pulls back the curtain on the hard truths that shape our world, diving into the bloody history and cold calculations that drive geopolitics. Using the concept of “realpolitik” as his lens, Tom explores why nations act not according to ideals, but ruthless self-interest, and how this approach accurately predicts the cycles of…
  continue reading
 
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world.The Supreme Court ruled in favor of Gilead in an HIV prevention case, leaving decisions on coverage of the pre-exposure prophylaxis drug to a task force led by RFK Jr. A depression drug missed its phase II endpoint but show…
  continue reading
 
Audio roundup of selected biopharma industry content from Scrip over the business week ended June 27, 2025. In this episode: top drugs in the first quarter; deal trends at bio; Novo and Lilly’s obesity segmentation plans; Chinese firms at ADA; and five drugs that surpassed sales expectations. https://insights.citeline.com/scrip/podcasts/scrips-five…
  continue reading
 
Tai Lopez is living proof that the rich and famous entrepreneurial lifestyle is possible for the Millennial generation. Over the course of his career, he’s founded, invested in, advised, or mentored more than 20 multi-million dollar companies, and his book club and podcast reaches 1.4 million people across 40 countries. But don’t be blinded by the …
  continue reading
 
The S&P 500 and Nasdaq both jump to fresh record highs, but pull back quickly as U.S.-Canada trade discussions screech to a halt. Plus Big bank stress test results, Nike’s best day since 2021, and Trump-Powell tensions run high, as Wall Street buzzes with potential for the president to name a Fed successor early. Fast Money Disclaimer…
  continue reading
 
Two and a half years into his tenure as Teva’s CEO, Richard Francis is breaking down the strategy that’s powered the company through nine consecutive quarters of growth. On this week’s episode of "The Top Line," Fierce Pharma’s Fraiser Kansteiner sits down with Francis to talk about the progress made so far on Teva’s “Pivot to Growth” strategy and …
  continue reading
 
In this special live episode, Tom dives headfirst into the chaos of current world events, unpacking everything from the explosive end of the 12-day war between Israel and Iran to the dramatic political shifts in New York. Alongside lively audience questions and his co-host Drew, Tom tackles some of the most hotly debated issues of our time: sociali…
  continue reading
 
Stocks climbing across the board, with the S&P 500 just points away from a fresh record high. How a quiet stealth rally in one sector could push the index to new heights. Plus Nike results are out. The details and numbers from its latest quarter, and the new faces joining the coffee chain’s board of directors. Fast Money Disclaimer…
  continue reading
 
We invite STAT’s senior writer for infectious diseases, Helen Branswell, and Washington correspondent Chelsea Cirruzzo on to the podcast to discuss the latest news at the CDC. The agency is in the spotlight once again, after the Senate grilled the potential head of the agency at a confirmation hearing and its federal vaccine advisory committee met …
  continue reading
 
What’s up, guys? Today I’m bringing you one of the most timely and thought-provoking episodes we’ve ever done. There’s no guest joining me in the traditional sense, but we are diving deep, breaking down the wild week on the global stage: the end of the 12-day war between Israel and Iran, Trump shaking up world politics and being nominated for the N…
  continue reading
 
Loading …

Quick Reference Guide

Copyright 2025 | Privacy Policy | Terms of Service | | Copyright
Listen to this show while you explore
Play